Your browser doesn't support javascript.
loading
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases.
Hilbers, Marie-Luise; Dimitriou, Florentia; Lau, Peter; Bhave, Prachi; McArthur, Grant A; Zimmer, Lisa; Kudura, Ken; Gérard, Camille L; Levesque, Mitchell P; Michielin, Olivier; Dummer, Reinhard; Cheng, Phil F; Mangana, Joanna.
Affiliation
  • Hilbers ML; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Dimitriou F; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Lau P; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Bhave P; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • McArthur GA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Zimmer L; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Kudura K; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
  • Gérard CL; Precision Oncology Center, Department of Oncology, Lausanne University Hospital CHUV, Lausanne, Switzerland.
  • Levesque MP; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Michielin O; Precision Oncology Center, Department of Oncology, Lausanne University Hospital CHUV, Lausanne, Switzerland.
  • Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. Electronic address: reinhard.dummer@usz.ch.
  • Cheng PF; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Mangana J; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Eur J Cancer ; 156: 149-163, 2021 10.
Article in En | MEDLINE | ID: mdl-34454317

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Protein Kinase Inhibitors / Immune Checkpoint Inhibitors / Melanoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa / Oceania Language: En Journal: Eur J Cancer Year: 2021 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Protein Kinase Inhibitors / Immune Checkpoint Inhibitors / Melanoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa / Oceania Language: En Journal: Eur J Cancer Year: 2021 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom